会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 차나무의 잎, 꽃 및 씨 추출물을 포함하는 대사 증후군 예방 또는 개선용 조성물
    • 用于预防或改善包含茶叶,花卉和种子提取物的代谢综合症的组合物
    • KR1020130078387A
    • 2013-07-10
    • KR1020110147304
    • 2011-12-30
    • (주)아모레퍼시픽
    • 김수경신현정라찬수김승훈이범진김영경서대방김완기정진오이상준
    • A61K36/82A61P3/00
    • A61K36/82
    • PURPOSE: A composition containing a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients is provided to activate AMP-activated protein kinase (AMPK), to suppress fatty acid synthesis, and to promote fatty acid oxidation and glucose absorption, thereby preventing and treating metabolic syndrome. CONSTITUTION: A composition for preventing or treating metabolic syndrome contains a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients, in a weight ratio of 4-12:0.3-4:0.3-4. The composition contains the Camellia sinensis leaf extract and the Camellia sinensis flower and seed extracts in a weight ratio of 4-12:0.2-8. The metabolic syndrome is a glucoside metabolic syndrome or a lipid metabolic syndrome. The metabolic syndrome includes one or more among obesity, hyperlipidemia, type 2 diabetes, arteriosclerosis, myocardial infarction, and angina pectoris. The composition is a pharmaceutical composition. [Reference numerals] (AA) Mixture of Camellia sinensis leaf, flower, and seed extracts; (BB) Camellia sinensis flower extract; (CC) Camellia sinensis seed extract; (DD) Camellia sinensis leaf extract
    • 目的:提供含有山茶叶提取物,山茶花提取物和山茶种子提取物作为活性成分的组合物,以激活AMP活化蛋白激酶(AMPK),抑制脂肪酸合成,促进脂肪酸 氧化和葡萄糖吸收,从而预防和治疗代谢综合征。 构成:用于预防或治疗代谢综合征的组合物含有山茶花提取物,山茶花提取物和山茶种子提取物作为活性成分,重量比为4-12:0.3-4:0.3-4。 该组合物含有山茶叶提取物和山茶花和种子提取物,重量比为4-12:0.2-8。 代谢综合征是葡萄糖苷代谢综合征或脂代谢综合征。 代谢综合征包括肥胖,高脂血症,2型糖尿病,动脉硬化,心肌梗塞和心绞痛中的一种或多种。 组合物是药物组合物。 (参考号)(AA)山茶叶,花和种子提取物的混合物; (BB)山茶花提取物; (CC)山茶籽提取物; (DD)山茶叶提取物
    • 5. 发明公开
    • 콩 추출물을 포함하는 탈모 방지 또는 육모 촉진용 조성물
    • 用于防止脱发的组合物或促进生长包含豆提取物的毛发
    • KR1020120136581A
    • 2012-12-20
    • KR1020110055597
    • 2011-06-09
    • (주)아모레퍼시픽
    • 전희영김승훈신현정서대방김수경
    • A61K8/97A61Q7/00A61Q5/00
    • A61K8/97A61Q5/00A61Q7/00A61Q7/02
    • PURPOSE: A composition containing soybean extract is provided to supply nutrient to epidermal cells of hair root, to prevent hair loss, and to promote hair growth. CONSTITUTION: A composition for preventing hair loss or promoting hair growth contains 0.001-90 wt% of soybean extract as an active ingredient, prepared by extracting 1-70%(v/v) C1-C5 alcohol. A composition for enhancing hair health contains the soybean extract as an active ingredient. The C1-C5 alcohols are methanol, ethanol, isopropyl alcohol, n-propyl alcohol, n-butanol, or isobutanol. The composition is applied to a cosmetic, food, or pharmaceutical composition. [Reference numerals] (AA) Control group; (BB) Embodiment 4; (CC) Embodiment 2
    • 目的:提供含有大豆提取物的组合物,以向头发根的表皮细胞提供营养,以防止脱发,并促进头发生长。 构成:通过提取1-70%(v / v)C 1 -C 5醇制备的用于防止脱发或促进毛发生长的组合物含有0.001-90重量%的大豆提取物作为活性成分。 用于增强毛发健康的组合物含有大豆提取物作为活性成分。 C1-C5醇是甲醇,乙醇,异丙醇,正丙醇,正丁醇或异丁醇。 该组合物用于化妆品,食品或药物组合物。 (附图标记)(AA)对照组; (BB)实施例4; (CC)实施例2
    • 10. 发明公开
    • 시링가레시놀을 포함하는 눈 질환 개선용 조성물
    • 用于改善包含SYRINGARESINOL的眼部疾病的组合物
    • KR1020130044712A
    • 2013-05-03
    • KR1020110108914
    • 2011-10-24
    • (주)아모레퍼시픽
    • 김수경조시영박찬웅서대방김완기이상준
    • A61K31/34A61K31/36A61P27/02
    • PURPOSE: A composition containing syringaresinol for treating eye diseases is provided to normalize the function of mitochondria and to prevent or treat eye diseases especially age-related eye diseases. CONSTITUTION: A composition for preventing or treating eye diseases contains 1-80 wt% of syringaresinol. The eye diseases are selected from the group consisting of macular degeneration, uveitis, glaucoma, diabetic retinopathy, and cataract. Syringaresinol is contained in extracts prepared using one or more selected among linseed, Phellodendron amurense Ruprecht, Acanthopanax senticosus, sesame seeds, and ginseng fruits. The composition enhances SIRT 1 expression and mitochondria synthesis. [Reference numerals] (AA) SIRT1 protein expression
    • 目的:提供一种含有用于治疗眼睛疾病的丁香ares醇的组合物,用于标准化线粒体的功能,并预防或治疗眼睛疾病,特别是年龄相关的眼睛疾病。 构成:用于预防或治疗眼睛疾病的组合物含有1-80重量%的丁香胺。 眼疾病选自黄斑变性,葡萄膜炎,青光眼,糖尿病性视网膜病变和白内障。 使用一种或多种选自亚麻籽,Phellodendron amurense Ruprecht,Acanthopanax senticosus,芝麻和人参果实中制备的提取物中含有Syringaresinol。 该组合物增强SIRT1表达和线粒体合成。 (AA)SIRT1蛋白表达